Korrektur
Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors
Stem Cells · 22.07.2026 · 44 (8)
DOI: 10.1093/stmcls/sxag034 ↗Kurz gefasst
Korrektur in der Zeitschrift Stem Cells, online erschienen am 30.07.2026.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
(2026). Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors. Stem Cells, 44(8). https://doi.org/10.1093/stmcls/sxag034
Vancouver
Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors. Stem Cells. 2026;44(8). doi:10.1093/stmcls/sxag034
BibTeX
@article{euvimed2026,
title = {Correction to: Therapeutic Efficacy and Fate of Bimodal Engineered Stem Cells in Malignant Brain Tumors},
journal = {Stem Cells},
year = {2026},
volume = {44},
number = {8},
doi = {10.1093/stmcls/sxag034}
}
EUVIMED